Opportunity Information: Apply for PAR 07 024
Apply for PAR 07 024
- The National Institutes of Health in the food and nutrition health sector is offering a public funding opportunity titled "Ancillary Studies to Major Ongoing NIDDK and NHLBI Clinical Research Studies (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.837 Cardiovascular Diseases Research 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research.
- This funding opportunity was created on Dec 5, 2008 and posted on Nov 20, 2006.
- Applicants must submit their applications by Multiple Receipt Dates See Link to Full Announcement for details.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Public housing authorities/Indian housing authorities Others (see text field entitled Additional Information on Eligibility for clarification) For profit organizations other than small businesses Small businesses County governments Public and State controlled institutions of higher education City or township governments State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) Special district governments Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education.
- Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith based or community based organizations can apply.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Ancillary Studies to Major Ongoing NIDDK and NHLBI Clinical Research Studies (R01)" (Funding Opportunity Number PAR-07-024) is an NIH funding announcement designed to support new, add-on research projects that piggyback on large clinical studies that are already underway. The central idea is to let investigators ask additional, well-justified scientific questions by leveraging the infrastructure, participants, data systems, and follow-up procedures of existing major clinical research efforts. Rather than starting an entirely new clinical trial or cohort from scratch, applicants propose an "ancillary study" that attaches to a parent study, making the research faster and often more cost-efficient while still producing meaningful new findings.
The program is jointly tied to two NIH institutes: the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Heart, Lung, and Blood Institute (NHLBI). The specific objective is cross-institute enrichment: it aims to bring NIDDK-oriented ancillary research into either NIDDK-funded or NHLBI-funded parent studies, and likewise to bring NHLBI-oriented ancillary research into NIDDK-funded parent studies. In practical terms, that means a researcher might add diabetes, kidney, digestive, nutrition, or metabolic-focused measures to an ongoing heart or lung study, or add cardiovascular, pulmonary, or blood-related measures to an ongoing NIDDK-supported study. The parent studies can include large clinical trials, epidemiological studies, and disease databases, so the announcement is not limited to one particular study design as long as the parent resource is a major ongoing clinical research activity supported by NIDDK or NHLBI.
Funding is provided through the NIH Research Project Grant mechanism (R01). That signals a standard investigator-initiated research award structure, with peer review and the expectation of a strong scientific rationale, feasibility, and a clear plan for executing the ancillary work within the constraints of the parent study. The announcement does not set a single fixed budget cap or project length because it anticipates that ancillary studies can range widely in complexity, from relatively modest additions (for example, adding a targeted biomarker panel, specialized imaging, additional questionnaires, or an outcomes adjudication component) to more substantial embedded projects (for example, collecting and analyzing new biospecimens, adding mechanistic substudies, or implementing new follow-up assessments). As a result, the size and duration of awards vary by proposal, and the total number of awards depends on the volume of applications received and, most importantly, their quality, scientific merit, and cost.
The opportunity is categorized as a discretionary grant program under NIH, with activity areas connected to cardiovascular diseases research (CFDA 93.837) and diabetes, digestive, and kidney diseases extramural research (CFDA 93.847). There is no cost-sharing or matching requirement, which means applicants are not required to commit non-federal matching funds as a condition of eligibility. Application due dates are described as multiple receipt dates, indicating that submissions were accepted on scheduled cycles rather than a single one-time deadline, with applicants directed to the full announcement for the specific timing details that applied while the FOA was active.
Eligibility is broad and includes many types of organizations. Public and private institutions of higher education can apply, as can nonprofits (including those with and without 501(c)(3) status), state and local governments (including counties, cities/townships, special districts, and independent school districts), Native American tribal governments and other tribal organizations, public housing authorities/Indian housing authorities, small businesses, and for-profit organizations other than small businesses. The eligibility language also specifies that foreign institutions are eligible to apply, that eligible federal agencies may apply, and that faith-based or community-based organizations may apply. This wide eligibility aligns with NIH norms for R01 opportunities, where the emphasis is typically on scientific capability, access to the parent study resource, and the ability to carry out the proposed work.
Overall, the FOA is aimed at maximizing the scientific return on existing large NIH-funded clinical research investments by encouraging creative, scientifically rigorous add-on studies that can be integrated into ongoing NIDDK and NHLBI parent projects. Applicants would generally need to demonstrate that the ancillary study is well aligned with the mission interests of the relevant institute, that it can be executed without compromising the integrity or primary aims of the parent study, and that the parent study infrastructure and leadership are able to accommodate the additional procedures, data collection, and analysis plans. For full operational details, the original announcement is linked through NIH at http://grants.nih.gov/grants/guide/pa-files/PAR-07-024.html, and NIH Office of Extramural Research support contacts are provided for access or technical linking issues.
Frequently Asked Questions (FAQs)
What is the "Ancillary Studies to Major Ongoing NIDDK and NHLBI Clinical Research Studies (R01)" opportunity?
This NIH funding opportunity (Funding Opportunity Number PAR-07-024) supports ancillary studies, meaning new, add-on research projects that attach to major clinical research studies that are already underway. The goal is to answer additional, well-justified scientific questions by using the existing parent study's infrastructure, participants, data systems, and follow-up procedures, rather than launching a brand-new clinical study from scratch.
What does "ancillary study" mean in this context?
An ancillary study is an embedded or add-on project that "piggybacks" on a larger ongoing clinical research effort (the parent study). It leverages the parent study's established operations (such as recruitment, data collection systems, visits, and follow-up), while proposing additional measurements, data collection, specimens, analyses, or assessments to generate new scientific findings.
Which NIH institutes are involved?
The opportunity is jointly tied to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Heart, Lung, and Blood Institute (NHLBI).
What is the main purpose of the program across NIDDK and NHLBI?
The program is designed for cross-institute enrichment. It encourages NIDDK-oriented ancillary research to be added to either NIDDK-funded or NHLBI-funded parent studies, and it also encourages NHLBI-oriented ancillary research to be added to NIDDK-funded parent studies.
What kinds of scientific topics could be added as ancillary studies?
Examples described include adding diabetes, kidney, digestive, nutrition, or metabolic-focused measures to an ongoing heart or lung study, or adding cardiovascular, pulmonary, or blood-related measures to an ongoing NIDDK-supported study. The overall expectation is that the ancillary questions are scientifically meaningful and aligned with the relevant institute mission interests.
What types of parent studies can an ancillary study attach to?
The parent study can be a major ongoing clinical research activity supported by NIDDK or NHLBI, including large clinical trials, epidemiological studies, and disease databases. The key requirement is that the parent resource is a major ongoing clinical research effort with infrastructure that can support the ancillary work.
What funding mechanism is used for this opportunity?
Funding is provided through the NIH Research Project Grant (R01) mechanism. This reflects a standard investigator-initiated award structure with peer review and expectations for strong scientific rationale and feasibility.
Is there a fixed budget cap or a fixed project period length?
No single fixed budget cap or fixed project length is specified in the provided information. The announcement anticipates wide variation in ancillary study scope, complexity, size, and duration, so budgets and project periods vary by proposal.
What are examples of the size or scope of ancillary studies that might be proposed?
Ancillary studies can range from modest additions (such as a targeted biomarker panel, specialized imaging, additional questionnaires, or an outcomes adjudication component) to more substantial embedded projects (such as collecting and analyzing new biospecimens, adding mechanistic substudies, or implementing new follow-up assessments).
How many awards will be made under this opportunity?
The total number of awards depends on the number of applications received and, most importantly, their quality, scientific merit, and cost.
Is cost sharing or matching required?
No. There is no cost-sharing or matching requirement stated, meaning applicants are not required to provide non-federal matching funds as a condition of eligibility.
What are the related CFDA program areas for this grant?
The opportunity is connected to cardiovascular diseases research (CFDA 93.837) and diabetes, digestive, and kidney diseases extramural research (CFDA 93.847).
Who is eligible to apply?
Eligibility is broad. Eligible applicants include public and private institutions of higher education; nonprofits (with and without 501(c)(3) status); state and local governments (including counties, cities/townships, special districts, and independent school districts); Native American tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; small businesses; and for-profit organizations other than small businesses.
Are foreign institutions eligible?
Yes. The eligibility language provided states that foreign institutions are eligible to apply.
Can federal agencies apply?
Yes. The eligibility language provided indicates that eligible federal agencies may apply.
Are faith-based or community-based organizations eligible?
Yes. The eligibility language provided states that faith-based or community-based organizations may apply.
Does the opportunity require creating a new clinical trial or cohort?
No. The central idea is to avoid starting an entirely new clinical study when feasible. Instead, applicants propose an ancillary study that leverages an existing major ongoing NIDDK- or NHLBI-supported clinical research effort.
What does an applicant generally need to demonstrate to be competitive?
Based on the description provided, applicants would generally need to demonstrate that the ancillary study is well aligned with the mission interests of the relevant institute, can be carried out feasibly within the parent study setting, does not compromise the integrity or primary aims of the parent study, and can be accommodated by the parent study's infrastructure and leadership.
Do applications follow a single deadline or multiple receipt dates?
The due dates are described as multiple receipt dates, meaning submissions were accepted on scheduled cycles rather than a one-time deadline. Applicants were directed to the full announcement for the specific timing details that applied while the FOA was active.
Where can the full original funding announcement be found?
The original announcement is linked through NIH at: http://grants.nih.gov/grants/guide/pa-files/PAR-07-024.html.
Who should be contacted for technical issues related to the announcement link?
The provided information notes that NIH Office of Extramural Research support contacts are provided for access or technical linking issues (specific names or contact details are not included in the summary provided here).
Browse more opportunities from the same category: Food and Nutrition Health
Next opportunity: Non Invasive Methods for Diagnosis and Progression of Diabetes, Kidney, Urological, Hematological and Digestive Diseases (R01)
Previous opportunity: Basic Research in the Bladder and Lower Urinary Tract (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 07 024
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 07 024) also looked into and applied for these:
| Funding Opportunity |
|---|
| Non Invasive Methods for Diagnosis and Progression of Diabetes, Kidney, Urological, Hematological and Digestive Diseases (R01) Apply for PA 07 025 Funding Number: PA 07 025 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Health Disparities in NIDDK Diseases (R01) Apply for PA 07 027 Funding Number: PA 07 027 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| NIDDK Multi Center Clinical Study Implementation Planning Grants (U34) Apply for PAR 08 057 Funding Number: PAR 08 057 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL) (U01) Apply for RFA DK 09 003 Funding Number: RFA DK 09 003 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $250,000 |
| Ancillary Studies in Immunomodulation Clinical Trials (R01) Apply for RFA AI 08 011 Funding Number: RFA AI 08 011 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| NIDDK Mentored Research Scientist Development Award (K01) Apply for PAR 09 060 Funding Number: PAR 09 060 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| George M. OBrien Urology Research Centers (P50) Apply for RFA DK 08 016 Funding Number: RFA DK 08 016 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Multiethnic Study of Type 2 Diabetes Genes (U01) Apply for RFA DK 09 004 Funding Number: RFA DK 09 004 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $500,000 |
| Limited Competition Continuation of the Clinical Islet Transplantation (CIT) Consortium (U01) Apply for RFA DK 09 501 Funding Number: RFA DK 09 501 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Chronic Kidney Disease Biomarker Discovery and Validation Consortium (U01) Apply for RFA DK 08 015 Funding Number: RFA DK 08 015 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $500,000 |
| Pilot and Feasibility Clinical Research Grants in Kidney or Urologic Diseases (R21) Apply for PAR 09 077 Funding Number: PAR 09 077 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $200,000 |
| Small Business Innovation Research Competing Renewal Awards for Biomedical and Behavior Research Tools (SBIR R44) Apply for PA 08 115 Funding Number: PA 08 115 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Diabetes Research Centers (P30, P60) Apply for RFA DK 08 008 Funding Number: RFA DK 08 008 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Integrated Research, Education, and Extension Competitive Grant Program National Integrated Food Safety Initiative Apply for USDA CSREES ICGP 002098 Funding Number: USDA CSREES ICGP 002098 Agency: CSREES Category: Food and Nutrition Health Funding Amount: $2,000,000 |
| Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21) Apply for PA 09 131 Funding Number: PA 09 131 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $200,000 |
| Pilot and Feasibility Clinical Research Grants in Diabetes, Endocrine and Metabolic Diseases (R21) Apply for PA 09 133 Funding Number: PA 09 133 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $200,000 |
| Silvio O. Conte Digestive Diseases Research Core Centers (P30) Apply for RFA DK 09 005 Funding Number: RFA DK 09 005 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $750,000 |
| Renal Function and Chronic Kidney Disease in Aging (R01) Apply for PA 09 165 Funding Number: PA 09 165 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Nutrition Obesity Research Centers (P30) Apply for RFA DK 09 006 Funding Number: RFA DK 09 006 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $750,000 |
| Non Invasive Methods for Diagnosis and Progression of Diabetes, Kidney, Urological, Hematological and Digestive Diseases and Hypertensive Disorders (R01) Apply for PA 09 181 Funding Number: PA 09 181 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 07 024", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
